Irene Kuo1, Halli Olsen2, Rudy Patrick2, Gregory Phillips3, Manya Magnus2, Jenevieve Opoku4, Anthony Rawls2, James Peterson2, Flora Hamilton5, Michael Kharfen4, Alan Greenberg2. 1. The George Washington University, Milken Institute School of Public Health, Washington, DC, United States. Electronic address: ikuo@gwu.edu. 2. The George Washington University, Milken Institute School of Public Health, Washington, DC, United States. 3. Northwestern University, Chicago, IL, United States. 4. HIV/AIDS, Hepatitis, STD, TB Administration, District of Columbia Department of Health, Washington, DC, United States. 5. Family and Medical Counseling Service, Inc., Washington, DC, United States.
Abstract
INTRODUCTION: Use of pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) has been shown to be effective in preventing HIV transmission. We examined correlates of the willingness to use PrEP among community-recruited older PWID in Washington, DC. METHODS: PWID were recruited using respondent-driven sampling (RDS) and completed a behavioral interview for the National HIV Behavioral Surveillance system in 2012. Participants reported on willingness to use PrEP and how it might affect their drug use and sexual behaviors. We reported RDS-weighted proportions and multivariable correlates of being willing to use PrEP. RESULTS: Among 304 participants, 69% were male, and the majority was aged ≥50 and black. Only 13.4% had ever heard of using anti-HIV medication to prevent HIV; none had ever used PrEP or knew anyone who used it in the past year. Forty-seven percent were very likely and 24% were somewhat likely to take PrEP if it were available without cost; 13% agreed they would not need to sterilize/clean needles or use condoms if taking PrEP. Correlates of being very likely to use PrEP included being younger (<50years), sharing cookers, cotton or water in the past year, and believing they would no longer need to use clean needles. CONCLUSION: Nearly half of PWID reported being very willing to use PrEP if it were available without cost. Younger PWID and those at higher risk of sharing cookers, cotton or water were more willing to use PrEP, suggesting a focus on these groups to explore PrEP use among PWID.
INTRODUCTION: Use of pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) has been shown to be effective in preventing HIV transmission. We examined correlates of the willingness to use PrEP among community-recruited older PWID in Washington, DC. METHODS: PWID were recruited using respondent-driven sampling (RDS) and completed a behavioral interview for the National HIV Behavioral Surveillance system in 2012. Participants reported on willingness to use PrEP and how it might affect their drug use and sexual behaviors. We reported RDS-weighted proportions and multivariable correlates of being willing to use PrEP. RESULTS: Among 304 participants, 69% were male, and the majority was aged ≥50 and black. Only 13.4% had ever heard of using anti-HIV medication to prevent HIV; none had ever used PrEP or knew anyone who used it in the past year. Forty-seven percent were very likely and 24% were somewhat likely to take PrEP if it were available without cost; 13% agreed they would not need to sterilize/clean needles or use condoms if taking PrEP. Correlates of being very likely to use PrEP included being younger (<50years), sharing cookers, cotton or water in the past year, and believing they would no longer need to use clean needles. CONCLUSION: Nearly half of PWID reported being very willing to use PrEP if it were available without cost. Younger PWID and those at higher risk of sharing cookers, cotton or water were more willing to use PrEP, suggesting a focus on these groups to explore PrEP use among PWID.
Authors: Rebecca B Hershow; Michelle Gonzalez; Elizabeth Costenbader; William Zule; Carol Golin; Lauren Brinkley-Rubinstein Journal: AIDS Educ Prev Date: 2019-08
Authors: Angela R Bazzi; Dea L Biancarelli; Ellen Childs; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Katie B Biello Journal: AIDS Patient Care STDS Date: 2018-10-11 Impact factor: 5.078
Authors: Emiko Kamitani; Megan E Wichser; Adebukola H Adegbite; Mary M Mullins; Wayne D Johnson; Pierre-Cedric Crouch; Theresa Ann Sipe Journal: AIDS Date: 2018-11-13 Impact factor: 4.177
Authors: Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver Journal: Drug Alcohol Depend Date: 2017-02-02 Impact factor: 4.492
Authors: Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb Journal: AIDS Behav Date: 2020-06
Authors: Catherine Tomko; Ju Nyeong Park; Sean T Allen; Jennifer Glick; Noya Galai; Michele R Decker; Katherine H A Footer; Susan G Sherman Journal: AIDS Patient Care STDS Date: 2019-01-11 Impact factor: 5.078
Authors: Susan G Sherman; Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Derrick Hunt; C Patrick Chaulk; Brian W Weir Journal: Drug Alcohol Depend Date: 2018-10-22 Impact factor: 4.492
Authors: Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein Journal: Int J Drug Policy Date: 2020-02-21